fitc-anti-il-6 Search Results


92
Miltenyi Biotec fitc anti il 6
Fitc Anti Il 6, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/fitc anti il 6/product/Miltenyi Biotec
Average 92 stars, based on 1 article reviews
fitc anti il 6 - by Bioz Stars, 2026-02
92/100 stars
  Buy from Supplier

90
Thermo Fisher anti-il6-fitc ebioscience 11–7061-82
Anti Il6 Fitc Ebioscience 11–7061 82, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti-il6-fitc ebioscience 11–7061-82/product/Thermo Fisher
Average 90 stars, based on 1 article reviews
anti-il6-fitc ebioscience 11–7061-82 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
ImmunoTools anti-il-6 fitc
Anti Il 6 Fitc, supplied by ImmunoTools, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti-il-6 fitc/product/ImmunoTools
Average 90 stars, based on 1 article reviews
anti-il-6 fitc - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

86
Thermo Fisher anti il 6 fitc
GADD34 deficiency alleviated acute liver injury after DEN treatment. a Representative time courses of three experiments in this study. Intraperitoneal injection (i.p.). Eut, euthanize. b H&E staining of liver sections in the indicated time points after 100 mg/kg DEN treatment (WT mice, n = 22; GADD34−/− mice, n = 22). Black arrows indicate central vein hypertension and necrosis, characterized by hepatocyte vacuolization. Scale bars 200 μm. *P < 0.05, **P < 0.01 versus WT. Histology score represented four samples in each time point and each group (six fields of view for each sample). c Measurement of mouse serum alanine aminotransferase (ALT) activity at the indicated time points after 100 mg/kg DEN treatment. Data from three independent trials are averaged for each time point. *P < 0.05 versus WT. d Representative RT-PCR result of GADD34 (Ppp1r15a) mRNA from WT mice at different times after 100 mg/kg DEN treatment. The statistical data for GADD34 mRNA are normalized to β-actin mRNA in three independent samples. ***P < 0.001, **P < 0.01 versus 0 h. e Real-time PCR analysis of pro-inflammatory <t>cytokine</t> <t>gene</t> <t>Il-6</t> and oncogene cMyc from WT and GADD34−/− mice at the indicated time points after 100 mg/kg DEN treatment. Data represent mean ± SEM of triplicates for each sample (n = 3). ***P < 0.001 **P < 0.01, *P < 0.05 versus WT; ns no significance versus WT. f Representative analysis of protein expression levels by Western blotting using liver samples from WT and GADD34−/− mice after 100 mg/kg DEN treatment. g Densitometric analysis of band intensities of pp53, pNF-κB, pSTAT3 and pAkt relative to p53, NF-κB, STAT3 and Akt after treatment with DEN. Data represent mean ± SEM of triplicates for samples. ***P < 0.001, **P < 0.01, *P < 0.05 versus WT; ns no significance versus WT
Anti Il 6 Fitc, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti il 6 fitc/product/Thermo Fisher
Average 86 stars, based on 1 article reviews
anti il 6 fitc - by Bioz Stars, 2026-02
86/100 stars
  Buy from Supplier

90
Thermo Fisher fitc-anti-il-6 ab 11-7061-81
GADD34 deficiency alleviated acute liver injury after DEN treatment. a Representative time courses of three experiments in this study. Intraperitoneal injection (i.p.). Eut, euthanize. b H&E staining of liver sections in the indicated time points after 100 mg/kg DEN treatment (WT mice, n = 22; GADD34−/− mice, n = 22). Black arrows indicate central vein hypertension and necrosis, characterized by hepatocyte vacuolization. Scale bars 200 μm. *P < 0.05, **P < 0.01 versus WT. Histology score represented four samples in each time point and each group (six fields of view for each sample). c Measurement of mouse serum alanine aminotransferase (ALT) activity at the indicated time points after 100 mg/kg DEN treatment. Data from three independent trials are averaged for each time point. *P < 0.05 versus WT. d Representative RT-PCR result of GADD34 (Ppp1r15a) mRNA from WT mice at different times after 100 mg/kg DEN treatment. The statistical data for GADD34 mRNA are normalized to β-actin mRNA in three independent samples. ***P < 0.001, **P < 0.01 versus 0 h. e Real-time PCR analysis of pro-inflammatory <t>cytokine</t> <t>gene</t> <t>Il-6</t> and oncogene cMyc from WT and GADD34−/− mice at the indicated time points after 100 mg/kg DEN treatment. Data represent mean ± SEM of triplicates for each sample (n = 3). ***P < 0.001 **P < 0.01, *P < 0.05 versus WT; ns no significance versus WT. f Representative analysis of protein expression levels by Western blotting using liver samples from WT and GADD34−/− mice after 100 mg/kg DEN treatment. g Densitometric analysis of band intensities of pp53, pNF-κB, pSTAT3 and pAkt relative to p53, NF-κB, STAT3 and Akt after treatment with DEN. Data represent mean ± SEM of triplicates for samples. ***P < 0.001, **P < 0.01, *P < 0.05 versus WT; ns no significance versus WT
Fitc Anti Il 6 Ab 11 7061 81, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/fitc-anti-il-6 ab 11-7061-81/product/Thermo Fisher
Average 90 stars, based on 1 article reviews
fitc-anti-il-6 ab 11-7061-81 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
R&D Systems anti-il-6-fitc
GADD34 deficiency alleviated acute liver injury after DEN treatment. a Representative time courses of three experiments in this study. Intraperitoneal injection (i.p.). Eut, euthanize. b H&E staining of liver sections in the indicated time points after 100 mg/kg DEN treatment (WT mice, n = 22; GADD34−/− mice, n = 22). Black arrows indicate central vein hypertension and necrosis, characterized by hepatocyte vacuolization. Scale bars 200 μm. *P < 0.05, **P < 0.01 versus WT. Histology score represented four samples in each time point and each group (six fields of view for each sample). c Measurement of mouse serum alanine aminotransferase (ALT) activity at the indicated time points after 100 mg/kg DEN treatment. Data from three independent trials are averaged for each time point. *P < 0.05 versus WT. d Representative RT-PCR result of GADD34 (Ppp1r15a) mRNA from WT mice at different times after 100 mg/kg DEN treatment. The statistical data for GADD34 mRNA are normalized to β-actin mRNA in three independent samples. ***P < 0.001, **P < 0.01 versus 0 h. e Real-time PCR analysis of pro-inflammatory <t>cytokine</t> <t>gene</t> <t>Il-6</t> and oncogene cMyc from WT and GADD34−/− mice at the indicated time points after 100 mg/kg DEN treatment. Data represent mean ± SEM of triplicates for each sample (n = 3). ***P < 0.001 **P < 0.01, *P < 0.05 versus WT; ns no significance versus WT. f Representative analysis of protein expression levels by Western blotting using liver samples from WT and GADD34−/− mice after 100 mg/kg DEN treatment. g Densitometric analysis of band intensities of pp53, pNF-κB, pSTAT3 and pAkt relative to p53, NF-κB, STAT3 and Akt after treatment with DEN. Data represent mean ± SEM of triplicates for samples. ***P < 0.001, **P < 0.01, *P < 0.05 versus WT; ns no significance versus WT
Anti Il 6 Fitc, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti-il-6-fitc/product/R&D Systems
Average 90 stars, based on 1 article reviews
anti-il-6-fitc - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

86
Thermo Fisher fitc anti il 6
Downregulating endogenous EPO production <t>increases</t> <t>IL-6</t> and MCP-1 production in macrophages. Intracellular <t>cytokine</t> production in CD11b + splenic macrophages isolated from B6.MRL/lpr shEPOrtTA POS (n=12) and shEPOrtTA NEG controls (n=10) at day 145 after DOX food initiation (flow cytometry). Mann–Whitney U test; ns, not significant, ** P < 0.01; *** P < 0.001 between B6.MRL/lpr shEPOrtTA POS and shEPOrtTA NEG groups.
Fitc Anti Il 6, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/fitc anti il 6/product/Thermo Fisher
Average 86 stars, based on 1 article reviews
fitc anti il 6 - by Bioz Stars, 2026-02
86/100 stars
  Buy from Supplier

90
Becton Dickinson fitc–anti-il-6
Downregulating endogenous EPO production <t>increases</t> <t>IL-6</t> and MCP-1 production in macrophages. Intracellular <t>cytokine</t> production in CD11b + splenic macrophages isolated from B6.MRL/lpr shEPOrtTA POS (n=12) and shEPOrtTA NEG controls (n=10) at day 145 after DOX food initiation (flow cytometry). Mann–Whitney U test; ns, not significant, ** P < 0.01; *** P < 0.001 between B6.MRL/lpr shEPOrtTA POS and shEPOrtTA NEG groups.
Fitc–Anti Il 6, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/fitc–anti-il-6/product/Becton Dickinson
Average 90 stars, based on 1 article reviews
fitc–anti-il-6 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Becton Dickinson anti-il-6-fitc
Downregulating endogenous EPO production <t>increases</t> <t>IL-6</t> and MCP-1 production in macrophages. Intracellular <t>cytokine</t> production in CD11b + splenic macrophages isolated from B6.MRL/lpr shEPOrtTA POS (n=12) and shEPOrtTA NEG controls (n=10) at day 145 after DOX food initiation (flow cytometry). Mann–Whitney U test; ns, not significant, ** P < 0.01; *** P < 0.001 between B6.MRL/lpr shEPOrtTA POS and shEPOrtTA NEG groups.
Anti Il 6 Fitc, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti-il-6-fitc/product/Becton Dickinson
Average 90 stars, based on 1 article reviews
anti-il-6-fitc - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Thermo Fisher anti-il10 apc
Downregulating endogenous EPO production <t>increases</t> <t>IL-6</t> and MCP-1 production in macrophages. Intracellular <t>cytokine</t> production in CD11b + splenic macrophages isolated from B6.MRL/lpr shEPOrtTA POS (n=12) and shEPOrtTA NEG controls (n=10) at day 145 after DOX food initiation (flow cytometry). Mann–Whitney U test; ns, not significant, ** P < 0.01; *** P < 0.001 between B6.MRL/lpr shEPOrtTA POS and shEPOrtTA NEG groups.
Anti Il10 Apc, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti-il10 apc/product/Thermo Fisher
Average 90 stars, based on 1 article reviews
anti-il10 apc - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Thermo Fisher anti-il-6 fitc 11-7061-41
Downregulating endogenous EPO production <t>increases</t> <t>IL-6</t> and MCP-1 production in macrophages. Intracellular <t>cytokine</t> production in CD11b + splenic macrophages isolated from B6.MRL/lpr shEPOrtTA POS (n=12) and shEPOrtTA NEG controls (n=10) at day 145 after DOX food initiation (flow cytometry). Mann–Whitney U test; ns, not significant, ** P < 0.01; *** P < 0.001 between B6.MRL/lpr shEPOrtTA POS and shEPOrtTA NEG groups.
Anti Il 6 Fitc 11 7061 41, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti-il-6 fitc 11-7061-41/product/Thermo Fisher
Average 90 stars, based on 1 article reviews
anti-il-6 fitc 11-7061-41 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Diaclone anti-il-6 fitc
Downregulating endogenous EPO production <t>increases</t> <t>IL-6</t> and MCP-1 production in macrophages. Intracellular <t>cytokine</t> production in CD11b + splenic macrophages isolated from B6.MRL/lpr shEPOrtTA POS (n=12) and shEPOrtTA NEG controls (n=10) at day 145 after DOX food initiation (flow cytometry). Mann–Whitney U test; ns, not significant, ** P < 0.01; *** P < 0.001 between B6.MRL/lpr shEPOrtTA POS and shEPOrtTA NEG groups.
Anti Il 6 Fitc, supplied by Diaclone, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti-il-6 fitc/product/Diaclone
Average 90 stars, based on 1 article reviews
anti-il-6 fitc - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

Image Search Results


GADD34 deficiency alleviated acute liver injury after DEN treatment. a Representative time courses of three experiments in this study. Intraperitoneal injection (i.p.). Eut, euthanize. b H&E staining of liver sections in the indicated time points after 100 mg/kg DEN treatment (WT mice, n = 22; GADD34−/− mice, n = 22). Black arrows indicate central vein hypertension and necrosis, characterized by hepatocyte vacuolization. Scale bars 200 μm. *P < 0.05, **P < 0.01 versus WT. Histology score represented four samples in each time point and each group (six fields of view for each sample). c Measurement of mouse serum alanine aminotransferase (ALT) activity at the indicated time points after 100 mg/kg DEN treatment. Data from three independent trials are averaged for each time point. *P < 0.05 versus WT. d Representative RT-PCR result of GADD34 (Ppp1r15a) mRNA from WT mice at different times after 100 mg/kg DEN treatment. The statistical data for GADD34 mRNA are normalized to β-actin mRNA in three independent samples. ***P < 0.001, **P < 0.01 versus 0 h. e Real-time PCR analysis of pro-inflammatory cytokine gene Il-6 and oncogene cMyc from WT and GADD34−/− mice at the indicated time points after 100 mg/kg DEN treatment. Data represent mean ± SEM of triplicates for each sample (n = 3). ***P < 0.001 **P < 0.01, *P < 0.05 versus WT; ns no significance versus WT. f Representative analysis of protein expression levels by Western blotting using liver samples from WT and GADD34−/− mice after 100 mg/kg DEN treatment. g Densitometric analysis of band intensities of pp53, pNF-κB, pSTAT3 and pAkt relative to p53, NF-κB, STAT3 and Akt after treatment with DEN. Data represent mean ± SEM of triplicates for samples. ***P < 0.001, **P < 0.01, *P < 0.05 versus WT; ns no significance versus WT

Journal: Cancer Immunology, Immunotherapy : CII

Article Title: Growth arrest and DNA damage-inducible protein (GADD34) enhanced liver inflammation and tumorigenesis in a diethylnitrosamine (DEN)-treated murine model

doi: 10.1007/s00262-015-1690-8

Figure Lengend Snippet: GADD34 deficiency alleviated acute liver injury after DEN treatment. a Representative time courses of three experiments in this study. Intraperitoneal injection (i.p.). Eut, euthanize. b H&E staining of liver sections in the indicated time points after 100 mg/kg DEN treatment (WT mice, n = 22; GADD34−/− mice, n = 22). Black arrows indicate central vein hypertension and necrosis, characterized by hepatocyte vacuolization. Scale bars 200 μm. *P < 0.05, **P < 0.01 versus WT. Histology score represented four samples in each time point and each group (six fields of view for each sample). c Measurement of mouse serum alanine aminotransferase (ALT) activity at the indicated time points after 100 mg/kg DEN treatment. Data from three independent trials are averaged for each time point. *P < 0.05 versus WT. d Representative RT-PCR result of GADD34 (Ppp1r15a) mRNA from WT mice at different times after 100 mg/kg DEN treatment. The statistical data for GADD34 mRNA are normalized to β-actin mRNA in three independent samples. ***P < 0.001, **P < 0.01 versus 0 h. e Real-time PCR analysis of pro-inflammatory cytokine gene Il-6 and oncogene cMyc from WT and GADD34−/− mice at the indicated time points after 100 mg/kg DEN treatment. Data represent mean ± SEM of triplicates for each sample (n = 3). ***P < 0.001 **P < 0.01, *P < 0.05 versus WT; ns no significance versus WT. f Representative analysis of protein expression levels by Western blotting using liver samples from WT and GADD34−/− mice after 100 mg/kg DEN treatment. g Densitometric analysis of band intensities of pp53, pNF-κB, pSTAT3 and pAkt relative to p53, NF-κB, STAT3 and Akt after treatment with DEN. Data represent mean ± SEM of triplicates for samples. ***P < 0.001, **P < 0.01, *P < 0.05 versus WT; ns no significance versus WT

Article Snippet: Anti-F4/80-APC (eBioscience, #17-4801) and anti-IL-6-FITC (eBioscience, #11-7061) were used at 1:500 dilutions and incubated at 4 °C overnight, after which the sections were washed with PBS and incubated with 4′,6-diamidino-2-phenylindole (DAPI) for 5 min. After rinsed with PBS, the sections were mounted with mounting fluid and visualized under A1Rsi inverted confocal microscopy (Nikon, Tokyo, Japan).

Techniques: Injection, Staining, Activity Assay, Reverse Transcription Polymerase Chain Reaction, Real-time Polymerase Chain Reaction, Expressing, Western Blot

GADD34 deficiency exhibited lower cytokine expression and hepatic compensatory proliferation after chronic DEN treatment. a Real-time PCR analysis of mRNA expression levels of the indicated genes in liver from WT and GADD34−/− mice after chronic DEN treatment. Data represent mean ± SEM of three independent experiments, *P < 0.05, ***P < 0.001 versus WT; ns no significance versus WT. b Representative immunofluorescent confocal microscopic images of tissues co-stained for F4/80 and IL-6 in liver tissues after chronic DEN treatment. Nuclei (4′,6-diamidino-2-phenylindole, DAPI), blue; IL-6, green; F4/80, pink. The red outlined areas are enlarged in top left corners. Scale bars 100 μm. c Statistical analysis of mean fluorescence intensity of IL-6 in Kupffer cells/macrophages. N = 3 with >8 fields of view for each group, *P < 0.05 versus WT, mean ± SEM. no significance versus WT. d Representative protein expression levels of liver samples from WT and GADD34−/− mice after chronic DEN treatment. e Analysis of hepatic compensatory proliferation by staining for Ki67. Black arrows indicate Ki67-positive cells. Scale bars 100 μm. Data represent mean ± SEM of three independent samples with >6 fields of view for each sample (LPF, low-power field). ***P < 0.001 versus WT. ns no significance versus WT

Journal: Cancer Immunology, Immunotherapy : CII

Article Title: Growth arrest and DNA damage-inducible protein (GADD34) enhanced liver inflammation and tumorigenesis in a diethylnitrosamine (DEN)-treated murine model

doi: 10.1007/s00262-015-1690-8

Figure Lengend Snippet: GADD34 deficiency exhibited lower cytokine expression and hepatic compensatory proliferation after chronic DEN treatment. a Real-time PCR analysis of mRNA expression levels of the indicated genes in liver from WT and GADD34−/− mice after chronic DEN treatment. Data represent mean ± SEM of three independent experiments, *P < 0.05, ***P < 0.001 versus WT; ns no significance versus WT. b Representative immunofluorescent confocal microscopic images of tissues co-stained for F4/80 and IL-6 in liver tissues after chronic DEN treatment. Nuclei (4′,6-diamidino-2-phenylindole, DAPI), blue; IL-6, green; F4/80, pink. The red outlined areas are enlarged in top left corners. Scale bars 100 μm. c Statistical analysis of mean fluorescence intensity of IL-6 in Kupffer cells/macrophages. N = 3 with >8 fields of view for each group, *P < 0.05 versus WT, mean ± SEM. no significance versus WT. d Representative protein expression levels of liver samples from WT and GADD34−/− mice after chronic DEN treatment. e Analysis of hepatic compensatory proliferation by staining for Ki67. Black arrows indicate Ki67-positive cells. Scale bars 100 μm. Data represent mean ± SEM of three independent samples with >6 fields of view for each sample (LPF, low-power field). ***P < 0.001 versus WT. ns no significance versus WT

Article Snippet: Anti-F4/80-APC (eBioscience, #17-4801) and anti-IL-6-FITC (eBioscience, #11-7061) were used at 1:500 dilutions and incubated at 4 °C overnight, after which the sections were washed with PBS and incubated with 4′,6-diamidino-2-phenylindole (DAPI) for 5 min. After rinsed with PBS, the sections were mounted with mounting fluid and visualized under A1Rsi inverted confocal microscopy (Nikon, Tokyo, Japan).

Techniques: Expressing, Real-time Polymerase Chain Reaction, Staining, Fluorescence

Schematic summary of this study. The chemical carcinogen diethylnitrosamine (DEN) led to DNA damage that in turn could enhance GADD34 upregulation. GADD34 augmented oncogene activation and the death of DEN-exposed hepatocytes through both pyroptosis and necrosis pathway. This process led to Kupffer cell/macrophage activation and immune cell infiltration that subsequently produced pro-tumorigenic cytokine and ROS, thereby stimulating the compensatory proliferation of surviving, mutant hepatocytes. Finally, abnormal proliferation enhanced HCC progression

Journal: Cancer Immunology, Immunotherapy : CII

Article Title: Growth arrest and DNA damage-inducible protein (GADD34) enhanced liver inflammation and tumorigenesis in a diethylnitrosamine (DEN)-treated murine model

doi: 10.1007/s00262-015-1690-8

Figure Lengend Snippet: Schematic summary of this study. The chemical carcinogen diethylnitrosamine (DEN) led to DNA damage that in turn could enhance GADD34 upregulation. GADD34 augmented oncogene activation and the death of DEN-exposed hepatocytes through both pyroptosis and necrosis pathway. This process led to Kupffer cell/macrophage activation and immune cell infiltration that subsequently produced pro-tumorigenic cytokine and ROS, thereby stimulating the compensatory proliferation of surviving, mutant hepatocytes. Finally, abnormal proliferation enhanced HCC progression

Article Snippet: Anti-F4/80-APC (eBioscience, #17-4801) and anti-IL-6-FITC (eBioscience, #11-7061) were used at 1:500 dilutions and incubated at 4 °C overnight, after which the sections were washed with PBS and incubated with 4′,6-diamidino-2-phenylindole (DAPI) for 5 min. After rinsed with PBS, the sections were mounted with mounting fluid and visualized under A1Rsi inverted confocal microscopy (Nikon, Tokyo, Japan).

Techniques: Activation Assay, Produced, Mutagenesis

GADD34 deficiency reduced HCC progression through attenuating macrophage infiltration, cytokine level, oncogene expression and hepatic proliferation. a Representative IHC images of non-tumor and tumor areas in liver samples from WT and GADD34−/− mice using anti-F4/80 antibody. The outlined areas are enlarged in the lower panel. Scale bars 50 μm. b Statistical analysis of F4/80-positive cells from different locations in different samples. N = 6 with >8 fields of view for each group, *P < 0.05, ***P < 0.001 versus WT, mean ± SEM. c–e Real-time PCR analysis of indicated genes in non-tumor and tumor areas from WT and GADD34−/− mice. N = 4 for each experiment. *P < 0.05, **P < 0.01 versus WT, mean ± SEM. f Representative IHC results of Ki67 expression in both non-tumor and tumor area. Scale bars 100 μm. g Statistical analysis of Ki67-positive cells in (f). N = 6 with >8 fields of view for each group, **P < 0.01 versus WT, mean ± SEM. no significance versus WT

Journal: Cancer Immunology, Immunotherapy : CII

Article Title: Growth arrest and DNA damage-inducible protein (GADD34) enhanced liver inflammation and tumorigenesis in a diethylnitrosamine (DEN)-treated murine model

doi: 10.1007/s00262-015-1690-8

Figure Lengend Snippet: GADD34 deficiency reduced HCC progression through attenuating macrophage infiltration, cytokine level, oncogene expression and hepatic proliferation. a Representative IHC images of non-tumor and tumor areas in liver samples from WT and GADD34−/− mice using anti-F4/80 antibody. The outlined areas are enlarged in the lower panel. Scale bars 50 μm. b Statistical analysis of F4/80-positive cells from different locations in different samples. N = 6 with >8 fields of view for each group, *P < 0.05, ***P < 0.001 versus WT, mean ± SEM. c–e Real-time PCR analysis of indicated genes in non-tumor and tumor areas from WT and GADD34−/− mice. N = 4 for each experiment. *P < 0.05, **P < 0.01 versus WT, mean ± SEM. f Representative IHC results of Ki67 expression in both non-tumor and tumor area. Scale bars 100 μm. g Statistical analysis of Ki67-positive cells in (f). N = 6 with >8 fields of view for each group, **P < 0.01 versus WT, mean ± SEM. no significance versus WT

Article Snippet: Anti-F4/80-APC (eBioscience, #17-4801) and anti-IL-6-FITC (eBioscience, #11-7061) were used at 1:500 dilutions and incubated at 4 °C overnight, after which the sections were washed with PBS and incubated with 4′,6-diamidino-2-phenylindole (DAPI) for 5 min. After rinsed with PBS, the sections were mounted with mounting fluid and visualized under A1Rsi inverted confocal microscopy (Nikon, Tokyo, Japan).

Techniques: Expressing, Real-time Polymerase Chain Reaction

Downregulating endogenous EPO production increases IL-6 and MCP-1 production in macrophages. Intracellular cytokine production in CD11b + splenic macrophages isolated from B6.MRL/lpr shEPOrtTA POS (n=12) and shEPOrtTA NEG controls (n=10) at day 145 after DOX food initiation (flow cytometry). Mann–Whitney U test; ns, not significant, ** P < 0.01; *** P < 0.001 between B6.MRL/lpr shEPOrtTA POS and shEPOrtTA NEG groups.

Journal: Frontiers in Immunology

Article Title: Endogenous erythropoietin has immunoregulatory functions that limit the expression of autoimmune kidney disease in mice

doi: 10.3389/fimmu.2023.1195662

Figure Lengend Snippet: Downregulating endogenous EPO production increases IL-6 and MCP-1 production in macrophages. Intracellular cytokine production in CD11b + splenic macrophages isolated from B6.MRL/lpr shEPOrtTA POS (n=12) and shEPOrtTA NEG controls (n=10) at day 145 after DOX food initiation (flow cytometry). Mann–Whitney U test; ns, not significant, ** P < 0.01; *** P < 0.001 between B6.MRL/lpr shEPOrtTA POS and shEPOrtTA NEG groups.

Article Snippet: After cell permeabilization using the eBioscience™ Foxp3/Transcription Factor Staining Buffer Set (Thermo Fisher Scientific), intracellular staining was performed using the following antibodies: FITC-anti-Foxp3, APC-anti-Foxp3 (clone FJK-16S), FITC-anti-IL-6 (clone MP520F3), and FITC-anti-MCP-1 (clone 2H5) (Thermo Fisher Scientific); Pacific Blue-anti-TNF-α (clone MP6-XT22), APC-anti-IL-10 (clone JES5-16E3), PE-Cy7-anti-IL-2 (clone JES6-5H4), BV421-anti-IFN-γ (clone XMG1.2), and PE-Cy7-anti-IL-4 (clone 11B11) (BioLegend).

Techniques: Isolation, Flow Cytometry, MANN-WHITNEY